Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
April 30, 2018 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 26, 2019 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 23, 2020 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 22, 2021 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 28, 2022 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
March 1, 2023 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 28, 2023 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 30, 2015 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
April 29, 2016 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
May 1, 2017 DEFA14A

Additional proxy soliciting materials - definitive

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us